Fgen stock: berger montague investigates potential securities fraud claims against fibrogen, inc. (fgen); lead plaintiff deadline is june 11, 2021

Philadelphia, pennsylvania--(newsfile corp. - may 21, 2021) - berger montague is investigating potential securities fraud claims against fibrogen, inc. ("fibrogen" or the "company") on behalf of investors who purchased fibrogen securities (nasdaq: fgen) between october 18, 2017 and april 6, 2021 (the "class period"). if you purchased fibrogen securities, have questions concerning your rights or interests, or would like to discuss berger montague's investigation, please contact attorneys andrew abramowitz at aabramowitz@bm.net or (215) 875-3015, or...
FGEN Ratings Summary
FGEN Quant Ranking